Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel de Paz

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Disease Markers|April 27, 2023
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell TransplantationCarmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, et al.
Thrombosis and Haemostasis|March 20, 2018
Factors Involved in Maintaining Haemostasis in Patients with Myelodysplastic SyndromeIhosvany Fernández Bello, Víctor Jiménez-Yuste, Raquel de Paz, et al.
Cancer|July 1, 2011
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndromeIris Cordoba, José R González-Porras, Benet Nomdedeu, et al.
Leukemia & Lymphoma|April 4, 2022
Infusion of haploidentical NKG2D-CAR-T<sub>CD45RA-</sub> cells in two pediatric patients with advanced relapsed and refractory acute leukemia was safe but achieved no clinical benefitsAdrián Fernández, Antonio Pérez-Martínez, Adela Escudero, et al.
The Pharmacogenomics Journal|February 5, 2020
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patientsJesús María Hernández Sánchez, Eva Lumbreras, María Díez-Campelo, et al.
Cancer|June 4, 2011
Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndromeJose Ramon Gonzalez-Porras, Iris Cordoba, Esperanza Such, et al.
Immunology|November 14, 2021
Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapyLara Herrera, Myriam Martin-Inaraja, Silvia Santos, et al.
Cytotherapy|December 30, 2022
Donor selection for adoptive cell therapy with CD45RA<sup>-</sup> memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma releaseKarima Al-Akioui-Sanz, Bárbara Pascual-Miguel, Mariana Díaz-Almirón, et al.
Journal of Clinical Immunology|January 19, 2021
Failure of Viral-Specific T Cells Administered in Pre-transplant Settings in Children with Inborn Errors of ImmunityLaura Alonso, Ana Méndez-Echevarría, Francesc Rudilla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric PatientsLuisa Sisinni, Mercedes Gasior, Raquel de Paz, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Disease Markers|April 27, 2023
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell TransplantationCarmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, et al.
Thrombosis and Haemostasis|March 20, 2018
Factors Involved in Maintaining Haemostasis in Patients with Myelodysplastic SyndromeIhosvany Fernández Bello, Víctor Jiménez-Yuste, Raquel de Paz, et al.
Cancer|July 1, 2011
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndromeIris Cordoba, José R González-Porras, Benet Nomdedeu, et al.
Leukemia & Lymphoma|April 4, 2022
Infusion of haploidentical NKG2D-CAR-T<sub>CD45RA-</sub> cells in two pediatric patients with advanced relapsed and refractory acute leukemia was safe but achieved no clinical benefitsAdrián Fernández, Antonio Pérez-Martínez, Adela Escudero, et al.
The Pharmacogenomics Journal|February 5, 2020
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patientsJesús María Hernández Sánchez, Eva Lumbreras, María Díez-Campelo, et al.
Cancer|June 4, 2011
Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndromeJose Ramon Gonzalez-Porras, Iris Cordoba, Esperanza Such, et al.
Immunology|November 14, 2021
Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapyLara Herrera, Myriam Martin-Inaraja, Silvia Santos, et al.
Cytotherapy|December 30, 2022
Donor selection for adoptive cell therapy with CD45RA<sup>-</sup> memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma releaseKarima Al-Akioui-Sanz, Bárbara Pascual-Miguel, Mariana Díaz-Almirón, et al.
Journal of Clinical Immunology|January 19, 2021
Failure of Viral-Specific T Cells Administered in Pre-transplant Settings in Children with Inborn Errors of ImmunityLaura Alonso, Ana Méndez-Echevarría, Francesc Rudilla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric PatientsLuisa Sisinni, Mercedes Gasior, Raquel de Paz, et al.
Pageof 7